5Fisher DA, Chew MH, Lim YT, Tambyah PA. Preventing local transmission of SARS: lessons from singapore. Med J Aust 2003;178:555-558.
6Stohr K. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet 2003; 361:1730-1733.
7So LK, Lau AC, Yam LY, Cheung TM, Poon E, Yung RW, Yuen KY. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet 2003; 361:1615-1617.
8The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308.
9Allegra L, Blasi F. Problems and perspectives in the treatment of respiratory infections caused by atypical pathogens. Pulm Pharmacol Ther 2001; 14:21-27.
10Atabai K, Matthay MA. The pulmonary physician in critical care.5: Acute lung injury and the acute respiratory distress syndrome:definitions and epidemiology. Thorax 2002; 57:452-458.
6Luby SP, Brooks WA, Zaman K, et al. infectious diseases and vaccine sciences: strategic directions[J]. J Heahh Popul Nutr, 2008,26(3):295-310.
7Phalipon A, Mulard I.A, Sansonetti PJ. Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path?[J]. Microbes Infect, 2008, 10(9): 1057-1062.
8Jafari F, Garcia-Gil LJ, Salmanzadeh-Ahrabi S, et al. Diagnosis and prevalence of enteropathogenic bacteria in children less than 5 years of age with acute diarrhea in Tehran children's hospitals[J]. J Infect, 2009,58(1):21-27.
9Castelli F, Capone S, Pedruzzi B, et al. Antimicrobial prevention and therapy for travelers' infection[J]. Expert Rev Anti Infect Ther, 2007,5(6): 1031 - 1048.
10Phalipon A,Tanguy M, Grandjean C, et al. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection[J]. J Immunol, 2009, 182(4):2241-2247.
